亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Pharmacotherapy for gastric and intestinal cramping pain: ‎ current and emerging therapies

医学 科克伦图书馆 临床试验 梅德林 重症监护医学 随机对照试验 内科学 政治学 法学
作者
Taraneh Mousavi,Mohammadhossein Sharifnia,Shekoufeh Nikfar,Mohammad Abdollahi
出处
期刊:Expert Opinion on Pharmacotherapy [Informa]
卷期号:24 (18): 2021-2033 被引量:1
标识
DOI:10.1080/14656566.2023.2265830
摘要

ABSTRACTIntroduction Acute gastrointestinal cramping pain (GICP) is a debilitating condition that affects many people worldwide, significantly reducing their quality of life. As such, prompt treatment is crucial.Areas covered This article will explore relevant literature from databases such as PubMed, Scopus, Google Scholar, Cochrane Library, and Web of Science. Additionally, we searched ClinicalTrials.gov and the WHO ICTRP database for the latest clinical trials.Expert opinion Consensus dictates that antispasmodics such as hyoscine-N-butyl bromide and mebeverine should be the primary treatment for GICP. If these prove ineffective, patients can switch to an antispasmodic with a different mode of action or add acetaminophen/NSAIDs for more severe cases. Currently, several antispasmodics are undergoing clinical trials, including drotaverine, alverine, pinaverium, otilonium bromide, fenoverine, tiropramide, otilonium bromide, trimebutine, and peppermint oil. Well-designed head-to-head studies are necessary to evaluate current antispasmodics' safety, efficacy, pharmacokinetic, and pharmacoeconomics profiles. Recent studies have shown that fixed-dose combinations of antispasmodics + NSAIDs or two different antispasmodics can improve patient compliance and synergistically reduce GICP. Therefore, it is recommended that the global availability and accessibility of these products be enhanced.KEYWORDS: Antispasmodiccrampsfunctional gastrointestinal disordergastric painhyoscinemebeverinespasmspasmolytic Article highlights Dealing with gastric and intestinal cramping pain (GICP) can be difficult due to the lack of a clear definition and global guidelines for managing this symptom, as well as poorly designed clinical studies.However, there are effective treatments available. The first line of treatment for GICP is antispasmodics such as hyoscine-N-butyl bromide and mebeverine. If these do not work, trying a different antispasmodic with another mechanism of action and adding NSAIDs/acetaminophen can be helpful.For centrally-mediated GICP, low-dose tricyclic antidepressants (TCAs) or selective serotonin reuptake inhibitors (SSRIs), benzodiazepines, or melatonin may be helpful.There are also new therapies emerging for managing GICP, like selective 5-HT3 antagonists, guanylate cyclase-C receptor agonists, fixed-dose combinations of antispasmodics and NSAIDs, or two antispasmodics.To improve the management of GICP and enhance the quality of life for those affected, we recommend conducting well-designed clinical studies and economic evaluations comparing the efficacy, safety, pharmacokinetic, and pharmacoeconomic profiles of available antispasmodics, developing GI-restricted, multi-target antispasmodics, or improving the pharmacokinetic profile of current agents.Declaration of interestThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.Reviewer disclosuresPeer reviewers on this manuscript have no relevant financial or other relationships to disclose.Additional informationFundingThis paper was not funded.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
薇伊完成签到,获得积分20
1分钟前
Sandy完成签到 ,获得积分10
1分钟前
深情安青应助科研通管家采纳,获得30
1分钟前
赘婿应助连安阳采纳,获得10
1分钟前
LiangRen完成签到 ,获得积分10
1分钟前
1分钟前
2分钟前
连安阳发布了新的文献求助10
2分钟前
腼腆的康发布了新的文献求助20
2分钟前
qianchang发布了新的文献求助200
2分钟前
连安阳完成签到,获得积分10
2分钟前
qianchang完成签到,获得积分10
3分钟前
腼腆的康完成签到 ,获得积分10
3分钟前
jerry完成签到 ,获得积分20
3分钟前
丘比特应助科研通管家采纳,获得10
3分钟前
wxl完成签到,获得积分10
4分钟前
PL完成签到,获得积分10
4分钟前
adcc102完成签到 ,获得积分10
4分钟前
4分钟前
欣嫩谷发布了新的文献求助10
4分钟前
cydanyanpi完成签到,获得积分10
5分钟前
5分钟前
5分钟前
松林揽月发布了新的文献求助10
5分钟前
传奇3应助科研通管家采纳,获得10
5分钟前
5分钟前
5分钟前
松林揽月发布了新的文献求助10
5分钟前
6分钟前
松林揽月发布了新的文献求助10
6分钟前
松林揽月发布了新的文献求助10
6分钟前
研友_VZG7GZ应助欢欢采纳,获得10
7分钟前
CipherSage应助科研通管家采纳,获得10
7分钟前
欢欢完成签到,获得积分10
7分钟前
7分钟前
7分钟前
7分钟前
Tim完成签到 ,获得积分10
8分钟前
8分钟前
彭于晏应助11111111采纳,获得10
8分钟前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Semiconductor Process Reliability in Practice 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 600
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3234564
求助须知:如何正确求助?哪些是违规求助? 2880908
关于积分的说明 8217339
捐赠科研通 2548510
什么是DOI,文献DOI怎么找? 1377809
科研通“疑难数据库(出版商)”最低求助积分说明 648006
邀请新用户注册赠送积分活动 623361